Refractive Cataract Surgery Essentials: Optimizing Outcomes | ASCRS
CME Activity
Refractive Cataract Surgery Essentials: Optimizing Outcomes
December 2019

CME Activity Details

Activity Availability

This CME activity is available free of charge for ASCRS Members. You do not currently have access to this activity.

Not logged in? Click the teal "Login" button in the upper right-hand corner and use your ASCRS member login.
Not a member? Learn more about ASCRS Membership.

Description

In this quick 45 minute CME activity based on content from the 2019 ASCRS Annual Meeting, join a panel of experts as they explore the essentials of treating and optimizing outcomes from refractive cataract surgery. View the detailed activity agenda listed below for presentation titles and speaker names.

CME Information

Credits: By completing this activity you will earn 0.75 AMA PRA Category 1 Credits™.
Activity Expiration Date: August 31, 2021

Learning Objectives

Upon successful completion of this activity, participants should be able to:

  • Describe essentials for measuring corneal astigmatism and the options for surgically managing astigmatism
  • Compare and contrast presbyopia-correcting IOL options, including identifying factors that impact this decision
  • Discuss post-operative measures for addressing suboptimal refractive outcomes
detailed activity agenda
What Is the Best Way to Measure Corneal Astigmatism?

Presented by Warren E. Hill, MD

Warren Hill, MD
How Do I Manage Astigmatism at the Time of Cataract Surgery?

Presented by Denise M. Visco, MD, MBA, ABO

When Should I Make Corneal Relaxing Incisions and When Should I Implant a Toric IOL?

Presented by Neal H. Shorstein, MD, ABO

What Should I Know about Presbyopia-Correcting IOLs?

Presented by Ehud I. Assia, MD

What Should I Know to Enhance a Suboptimal Refractive Outcome?

Presented by Kendall E. Donaldson, MD

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.